Blue Jet Healthcare informs about outcome of board meeting

07 Feb 2024 Evaluate
In terms with Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (SEBI Listing Regulations, 2015), Blue Jet Healthcare has informed that, the Board of Directors of the Company at their meeting held through physical mode at its Registered Office on Tuesday, February 6, 2024, have approved the Un-Audited Standalone Financial Results for the Third Quarter and Nine Months ended December 31, 2023. It has enclosed Unaudited Standalone Financial Results for the Third Quarter and Nine Months ended December 31, 2023 along with the Limited Review Report thereon, issued by the Statutory Auditors of the Company. The meeting commenced at 12:00 pm and concluded at 1:45 pm.

The above information is a part of company’s filings submitted to BSE.

Blue Jet Healthcare Share Price

563.85 -16.15 (-2.78%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.